Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study - Wikidata - wikimedia - TriplyDB

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study

http://www.wikidata.org/entity/Q35171276

about

Putting together the psoriasis puzzle: an update on developing targeted therapies Psoriasis and comorbid diseases: Epidemiology.Management of cardiovascular disease in patients with psoriasis.The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis.Vascular inflammation in psoriasis localizes to the arterial wall using a novel imaging technique.Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2014 MauiDerm Meeting Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initia IL-17A production in human psoriatic blood and lesions by CD146+ T cells.Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3 Assessing Cutaneous Psoriasis Activity Using FDG-PET: Nonattenuation Corrected Versus Attenuation Corrected PET Images.Chronic skin-specific inflammation promotes vascular inflammation and thrombosis.Increased 18F-FDG uptake suggests synovial inflammatory reaction with osteoarthritis: preliminary in-vivo results in humans.The impact of psoriasis on 10-year Framingham risk.Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and Aggregation Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study.Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile.Metabolic syndrome in patients with psoriatic disease.Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis.Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis.Feasibility of carotid artery PET/MRI in psoriasis patients Psoriasis severity and the prevalence of major medical comorbidity: a population-based study A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study.Perioperative stroke in a patient undergoing surgery for oral cancer: A case report Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors.High-density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right direction Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors.Psoriasis and Psoriatic Arthritis.Does treatment of psoriasis reduce the risk of cardiovascular disease?Impact of smoking on response to systemic treatment in patients with psoriasis: a retrospective case-control study.The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.The Link Between Inflammatory Disorders and Coronary Heart Disease: a Look at Recent Studies and Novel Drugs in Development.Psoriasis as a human model of disease to study inflammatory atherogenesis.Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis.Cardiometabolic Disorders in Psoriatic Disease.

P2860

Q27026785-262B900B-0829-4E24-B5B2-09C22AB114E9 Q30235889-797EB3C4-F2B0-4B57-B75A-5446B733D0A9 Q30250278-6FA9FC80-7074-4D7A-9CED-08691C484C35 Q33574671-B7CFBDBF-B483-45A1-943A-CE503C519154 Q33624882-8E57B213-5F2C-4AF8-B0FD-C14778AF1711 Q34377347-43EB75E5-4FA0-4B11-B54C-2A3F3DD83CF8 Q34434622-BBDEF9CE-0145-4BD2-B993-607DF955B29B Q34668556-421E499A-E6BC-4510-913D-C61B5F4AF29C Q34714063-D44F52AB-2461-4907-B04E-DD33C020E252 Q35962417-01642C91-80E0-4F42-930D-0E5D13BAD1F1 Q36108233-BD637280-DA63-4C38-849A-7E64C942E633 Q36110025-B62C0421-0A71-47C4-83CA-5292321C8040 Q36225333-02D82029-E6A0-4462-8B6B-FBFD596ACA30 Q36240763-EEAF855D-E7A3-4B0E-8C1F-268BC487C519 Q36305268-D37D5E65-B110-47DD-A7E6-11BEF4390C5A Q36326833-808A94F1-AD49-4AB0-82CE-89D8CE0CFE16 Q36390768-9EA64279-51E7-4697-9673-DCE0954A5C7F Q36404574-CEC34EED-C098-420D-BF04-C38955FD250C Q36514727-3E7622F3-9469-4BD0-8964-765AA3D74A0D Q36897095-7CDC671D-52DC-44DB-A176-06071A2F02A0 Q36914874-F4B2AF02-92F0-479F-9E20-EF7A3827D708 Q36957991-44C38F4F-0F13-4AE6-B241-13BC0960E8F6 Q37040371-2422580C-1D1F-4B15-B7EA-143B846F6A34 Q37152902-498DC627-7211-4C75-9650-C31FDF858902 Q37215507-ADC19884-7A30-4EAB-9929-64F32F861E2D Q37239394-0C1DB939-099B-4B55-B879-42FD2A2B7F55 Q37285410-308FAEFC-FA1A-4BDC-9B46-1757A08A685B Q37287455-8B60E14A-CAF6-4C3A-91AA-9C4A38576B8C Q37405750-665751CD-AC4D-4B7B-9D32-4E4669EE1F46 Q37593287-33000561-E47B-4419-87F6-C0BCEEE6F4B8 Q37648544-37977802-BD9A-46D6-B094-DE07ED86D720 Q37723047-08EEA5CC-0F94-420E-B31F-BA3DF0925EB8 Q38178202-A1B0D408-ACB2-4284-B550-C70F9B16AB2D Q38241734-E623B927-0B5E-4E55-BA30-9A9DB239A8CD Q38615718-6A35442F-2AE4-4EE9-B263-DA613E53198F Q38688816-F8E1B8ED-C81B-44EF-BE96-5CD0A66C16E2 Q39160397-8B8794EB-3158-4CD6-9CC0-5DFAF616C639 Q39165518-D59A1374-CE4C-4FD2-BE23-299CE4A69BB5 Q39267608-A4035327-02E9-42F4-ABB8-44C15FC411D7 Q40069191-9418AC74-0144-477D-8491-27D6E3E7901F

P2860

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study

http://www.wikidata.org/entity/Q35171276

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Systemic and vascular inflamma ...... hy (FDG-PET/CT): a pilot study

@ast

Systemic and vascular inflamma ...... hy (FDG-PET/CT): a pilot study

@en

type

label

Systemic and vascular inflamma ...... hy (FDG-PET/CT): a pilot study

@ast

Systemic and vascular inflamma ...... hy (FDG-PET/CT): a pilot study

@en

prefLabel

Systemic and vascular inflamma ...... hy (FDG-PET/CT): a pilot study

@ast

Systemic and vascular inflamma ...... hy (FDG-PET/CT): a pilot study

@en

P1433

Q35171276-A835D8DD-DCC6-49BC-BFFE-7EE2161966F9

P1476

Q35171276-20F86025-A6E0-4FC0-9D8F-63D4AFDC3054

P2093

Q35171276-34C7FFE4-7AE5-4127-97CB-82EBBD3CC0E5

Q35171276-438478D8-9BE4-41E5-9BC4-CB8959803DE9

Q35171276-6A8D4116-EAC6-40EA-B8CB-6EF896F56F92

Q35171276-800DBBD5-BCB1-480A-9005-166B39092FE9

Q35171276-9F0D5563-D825-4BA9-9B79-A3571F4E8DBD

Q35171276-A4B09741-2AC8-4B67-B7B1-1A8CEACC09CF

Q35171276-CEB8D41D-A2E4-4425-9DB0-D5445ECE8A3F

Q35171276-F92BB4EC-313C-4860-8C71-2F7F0C16DF30

P2860

Q35171276-02294DC5-A13C-43A2-A976-1A79DD498CB8

Q35171276-035A9175-32EF-4939-B5AC-9265BFF779F8

Q35171276-048F9C3D-E939-468C-8CFA-DFB55B59AC73

Q35171276-09C5817C-5E70-4F00-AB93-5EC3951CCFDF

Q35171276-0DD7064D-4042-4D36-86B2-E8C5544F1E16

Q35171276-11DCE90B-23B7-4C9B-AF1E-4E4291FF6E87

Q35171276-159CF106-323A-4E27-A674-39A288028B7A

Q35171276-217E8F99-4F57-47E7-97DC-9D6185CFEEDB

Q35171276-27EAFDA3-3BD3-4007-B269-086A147774C9

Q35171276-2B58AA0F-4BD7-46A6-9A36-C9722787DEC1

P304

Q35171276-71239FD0-EEB0-4F13-A91A-B360D1494396

P31

Q35171276-25A835E2-B8B0-45EC-8643-5C71A54BBF3B

P356

Q35171276-E0E90BEE-D376-42C3-B1F4-F400F633DAE9

P433

Q35171276-731713A1-B078-4EC0-AC58-D5E893253FBE

P478

Q35171276-62E87709-24E9-48B0-80F3-DAE4888218E0

P50

Q35171276-402F0D4E-1B1B-4289-B494-B06609F7CA01

Q35171276-A834463B-D027-407F-AB57-1F3CEE2DB9E3

Q35171276-FB770163-E2AE-4543-BEB2-36FFEB0F9A6F

Q35171276-FE941E99-FC19-4FC7-8F7B-11BAB850CBF4

P577

Q35171276-165D7211-0228-40F6-AAA9-826E7766C9C7

P5875

Q35171276-22E30E25-63FF-49B4-A9CF-B12E0CAAD823

P698

Q35171276-4232C478-0F1D-408E-AF52-56144430DDDC

P921

Q35171276-5769673A-EB1E-4C25-966B-2FF2E020654C

P932

Q35171276-8BDAFC07-127F-4750-B98C-ED7EF8A035D3

P356

ARCHDERMATOL.2011.119

P1433

JAMA Dermatology

P1476

Systemic and vascular inflamma ...... hy (FDG-PET/CT): a pilot study

@en

P2093

Abass Alavi

http://www.w3.org/2001/XMLSchema#string

Abby S Van Voorhees

http://www.w3.org/2001/XMLSchema#string

Amanda Baer

http://www.w3.org/2001/XMLSchema#string

Anna Raper

http://www.w3.org/2001/XMLSchema#string

Drew A Torigian

http://www.w3.org/2001/XMLSchema#string

Jules Antigua

http://www.w3.org/2001/XMLSchema#string

Negar Foroughi

http://www.w3.org/2001/XMLSchema#string

Nehal N Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Inflammation in atherosclerosis

Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses.

The risk of stroke in patients with psoriasis

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.

The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

P304

1031-1039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHDERMATOL.2011.119

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P50

Parasuram Krishnamoorthy

P577

2011-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51130873

http://www.w3.org/2001/XMLSchema#string

P698

21576552

http://www.w3.org/2001/XMLSchema#string

P921

P932

3158301

http://www.w3.org/2001/XMLSchema#string